BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin KT, Du WL, Liu YY, Lan HR, Si JX, Mou XZ. Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements. Cancers (Basel) 2021;13:588. [PMID: 33546172 DOI: 10.3390/cancers13040588] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Du L, Chen X. Oncolytic virus: A catalyst for the treatment of gastric cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1017692] [Reference Citation Analysis]
2 Al-haideri M, Tondok SB, Safa SH, maleki AH, Rostami S, Jalil AT, Al-gazally ME, Alsaikhan F, Rizaev JA, Mohammad TAM, Tahmasebi S. CAR-T cell combination therapy: the next revolution in cancer treatment. Cancer Cell Int 2022;22:365. [DOI: 10.1186/s12935-022-02778-6] [Reference Citation Analysis]
3 Jafari M, Kadkhodazadeh M, Shapourabadi MB, Goradel NH, Shokrgozar MA, Arashkia A, Abdoli S, Sharifzadeh Z. Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses. Front Immunol 2022;13:1012806. [DOI: 10.3389/fimmu.2022.1012806] [Reference Citation Analysis]
4 Hu LF, Lan HR, Huang D, Li XM, Jin KT. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand? Front Oncol 2021;11:769305. [PMID: 34888246 DOI: 10.3389/fonc.2021.769305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, Brooks AE, Pullan JE, Dailey KM. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel) 2021;11:3018. [PMID: 34835785 DOI: 10.3390/nano11113018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wang Z, Guo K, Liu Y, Huang C, Wu M. Dynamic impact of virome on colitis and colorectal cancer: Immunity, inflammation, prevention and treatment. Semin Cancer Biol 2021:S1044-579X(21)00254-6. [PMID: 34656791 DOI: 10.1016/j.semcancer.2021.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
7 Marchini A, Ilkow CS, Melcher A. Oncolytic Virus Immunotherapy. Cancers (Basel) 2021;13:3672. [PMID: 34359574 DOI: 10.3390/cancers13153672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kazemi MH, Kuhestani Dehaghi B, Roshandel E, Parkhideh S, Mehdizadeh M, Salimi M, Hajifathali A, Hamidpour M. Oncolytic virotherapy in hematopoietic stem cell transplantation. Hum Immunol 2021;82:640-8. [PMID: 34119352 DOI: 10.1016/j.humimm.2021.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]